Skip to main content

Table 2 Weighted average expenditures and standard deviations by type of depression treatment and gender, medicare current beneficiary survey, 2000-2005 a

From: Depression treatment and short-term healthcare expenditures among elderly Medicare beneficiaries with chronic physical conditions

Expenditures Antidepressants only Psych Tx (with or w/o AD) No treatment
  Mean $ SD $ p-value Mean $ SD $ p-value Mean $ SD $
Total 17,425 18,038.4 0.296 19,733 18,448.7 0.005 16,795 17,956.7
Inpatient 5,186 9,514.8 0.471 5,142 9,510.3 0.604 5,473 9,546.1
Outpatient 1,764 3,459.4 0.229 1,653 3,449.8 0.859 1,617 3,447.1
Medical provider 4,767 4,854.4 < 0.001 5,839 5,130.9 < 0.001 4,295 4,774.9
Prescription drugs 2,848 1,911.0 < 0.001 3,076 2,001.2 < 0.001 1,829 1,689.9
Other 2,530 9,510.6 < 0.001 3,656 9,498.9 0.352 3,330 9,493.8
  1. Note: Based on 1,055 elderly community-dwelling Medicare beneficiaries aged 65 years or older, and followed for one year during 2001 through 2005. Expenditures were measured in the follow-up year and depression treatment was measured in year 1. p-values can be used to identify statistically differences in expenditures by depression treatment compared to no depression treatment based on t-tests.
  2. aDue to small number of individuals who received only psychotherapy but no antidepressant treatment, we combined people having psychotherapy with and without antidepressant treatment into one group.
  3. p: p-value; SD: Standard Deviation; Tx: Treatment; AD: Antidepressants; Psych Tx (with or w/o AD): Psychotherapy with or without antidepressants.